Tuesday, November 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Freeport-McMoRan Shares Plunge Following Mine Tragedy and Production Halt

Robert Sasse by Robert Sasse
September 26, 2025
in Analysis, Commodities, Earnings, Industrial
0
Freeport-McMoRan Stock
0
SHARES
55
VIEWS
Share on FacebookShare on Twitter

A fatal incident at a key Indonesian mining operation has cast a shadow over Freeport-McMoRan’s growth trajectory, triggering a sharp decline in its stock value. The company was forced to declare force majeure on copper deliveries after a mudslide halted production at a critical facility, leading to a significant reduction in its sales forecast for the third quarter.

Market Reaction and Analyst Downgrades

The financial impact was immediate and severe. Freeport-McMoRan’s stock plummeted approximately 22 percent over a two-day period as investors reacted to the news. The market response was echoed by a wave of analyst downgrades. Several major financial institutions revised their recommendations and price targets downward, reflecting heightened risk perceptions.

  • BofA Securities adjusted its rating to “Neutral” and set a new price target of $42.00.
  • Scotiabank downgraded the stock to “Sector Perform,” slashing its target from $55 to $45.
  • UBS maintained a “Neutral” stance but reduced its target price to $42.50 from $50.00.

A contrasting view came from Bernstein, which surprisingly upgraded the shares to “Outperform,” citing an oversold position. However, the prevailing sentiment among market experts is one of caution. The timeline for a full recovery appears extended, with pre-incident production levels not anticipated until 2027. Preliminary estimates suggest Indonesian output for 2026 could be around 35 percent lower.

Should investors sell immediately? Or is it worth buying Freeport-McMoRan?

Operational Setback and Global Supply Impact

The crisis stems from a tragic mudflow on September 8 at the Grasberg Block Cave mine, which resulted in the death of two miners and left five others missing. This facility is of paramount importance, accounting for an estimated 70 percent of the company’s planned copper and gold production through 2029. With operations suspended indefinitely, Freeport-McMoRan now expects its Q3 copper sales to be roughly 4 percent lower, and gold sales about 6 percent lower, than its July forecast.

The disruption at one of the world’s largest copper mines has reverberated through global commodity markets, pushing copper prices upward due to anticipated supply constraints. The path to resuming operations remains uncertain. While other underground sections of the Grasberg complex might commence operations by the fourth quarter of 2025, a phased restart of the damaged Block Cave mine is not expected before the first half of 2026. An ongoing investigation by Indonesian authorities, which points to heavy rainfall as a potential cause, will be critical in determining the final schedule.

For shareholders, the situation remains fluid. The stock’s recovery is now directly tied to demonstrable progress in restoring production at the Indonesian site. Every subsequent corporate update and the conclusion of the official investigation will be scrutinized for signs of a rebound.

Ad

Freeport-McMoRan Stock: Buy or Sell?! New Freeport-McMoRan Analysis from November 11 delivers the answer:

The latest Freeport-McMoRan figures speak for themselves: Urgent action needed for Freeport-McMoRan investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 11.

Freeport-McMoRan: Buy or sell? Read more here...

Tags: Freeport-McMoRan
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

MP Materials Stock
Analysis

MP Materials Shares Surge on Defense Partnership and Production Milestones

November 11, 2025
The Trade Desk Stock
Analysis

The Trade Desk’s Puzzling Plunge: Strong Earnings Met With Steep Declines

November 11, 2025
ASML Stock
Analysis

Mixed Messages for ASML Investors

November 11, 2025
Next Post
S&P 500 Stock

Strong Economic Data Sparks Sell-Off in S&P 500

Cardiff Oncology Stock

Cardiff Oncology Shares Face Sustained Selling Pressure

Fannie Mae Stock

Political Headwinds Buffet Fannie Mae's Path to Privatization

Recommended

Trade Desk Stock

The Trade Desk Faces Shareholder Lawsuit Amid Insider Selling Allegations

1 month ago
Consumer Electronics Trading online

TE Connectivity Exceeds Expectations and Provides Positive Outlook for Fiscal Year 2024

2 years ago
Affirm Holdings Stock

Affirm Holdings Faces Investor Skepticism Amid Executive Share Sales

1 month ago
KBR Stock

KBR’s Strategic Crossroads: Legal Challenges Offset by Aerospace Wins

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Mixed Messages for ASML Investors

Strategic Retreat: Novo Nordisk Withdraws from Metsera Acquisition Battle

AMD’s Strategic Vision Takes Center Stage in New York

Apple’s Product Strategy Faces Unusual Setback

Nvidia Shares Flash Bullish Signal Ahead of Earnings Report

Meta Shares Under Pressure as Erste Group Sounds Alarm

Trending

Redcare Pharmacy Stock
E-Commerce

Redcare Pharmacy Appoints E-commerce Veteran as New Finance Chief

by Robert Sasse
November 11, 2025
0

In a strategic move to bolster its leadership team, Redcare Pharmacy has announced the appointment of a...

MP Materials Stock

MP Materials Shares Surge on Defense Partnership and Production Milestones

November 11, 2025
The Trade Desk Stock

The Trade Desk’s Puzzling Plunge: Strong Earnings Met With Steep Declines

November 11, 2025
ASML Stock

Mixed Messages for ASML Investors

November 11, 2025
Novo Nordisk Stock

Strategic Retreat: Novo Nordisk Withdraws from Metsera Acquisition Battle

November 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Redcare Pharmacy Appoints E-commerce Veteran as New Finance Chief
  • MP Materials Shares Surge on Defense Partnership and Production Milestones
  • The Trade Desk’s Puzzling Plunge: Strong Earnings Met With Steep Declines

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com